Covid-19 New

More Info

Open access Aims and Scope Instructions Editorial Guidelines Licensing Copyright

Author's satisfaction with

  • Friendly and hassle-free publication process
  • Less production time of articles
  • Constructive peer-review
  • Enhancing journal reputation
  • Regular feedback system
  • Quick response to authors' queries

Read More

Recently Viewed

Role of novel cardiac biomarkers for the diagnosis, risk str Late discover of a traumatic cardiac injury: Case report Timing of cardiac surgery and other intervention among child P wave dispersion in patients with premenstrual dysphoric di Preclinical stiff heart is a marker of cardiovascular morbim

Read More

Most Viewed

Evaluation of Biostimulants Based on Recovered Protein Hydro Sinonasal Myxoma Extending into the Orbit in a 4-Year Old: A Feasibility study of magnetic sensing for detecting single-n Pediatric Dysgerminoma: Unveiling a Rare Ovarian Tumor Physical activity can change the physiological and psycholog

Read More

Open Journals

Clinical Images

For Authors Guide For Authors Benefits For Authors Article Processing Charge How To Write a Scientific Paper How To Write a Review Article Short Communication
For Reviewers Benefits For Reviewers How To Review Thanks To Reviewers
For Editors Benefits For Editors Thanks To Editors

Abstract

Review Article

Central nervous system diseases associated with blood brain barrier breakdown - A Comprehensive update of existing literature

Rajib Dutta*

Published: 25 August, 2020 | Volume 4 - Issue 2 | Pages: 053-062

Blood vessels that supply and feed the central nervous system (CNS) possess unique and exclusive properties, named as blood–brain barrier (BBB). It is responsible for tight regulation of the movement of ions, molecules, and cells between the blood and the brain thereby maintaining controlled chemical composition of the neuronal milieu required for appropriate functioning. It also protects the neural tissue from toxic plasma components, blood cells and pathogens from entering the brain. In this review the importance of BBB and its disruption causing brain pathology and progression to different neurological diseases like Alzheimer’s disease (AD), Parkinson’s disease (PD), Amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD) etc. will be discussed.

Read Full Article HTML DOI: 10.29328/journal.jnnd.1001035 Cite this Article Read Full Article PDF

Keywords:

Blood brain barrier; Central nervous system; Neuronal functioning; Brain pathology; Neurological disease

References

  1. Zlokovic BV. The blood–brain barrier in health and chronic neurodegenerative disorders. Neuron. 2018; 57: 178–201. PubMed: https://pubmed.ncbi.nlm.nih.gov/18215617/
  2. Daneman R. The blood–brain barrier in health and disease. Ann Neurol. 2018; 72: 648–672. PubMed https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292164/
  3. Montagne A, Zhao Z, Zlokovic BV. Alzheimer’s disease: a matter of blood-brain barrier dysfunction? J Exp Med. 2017; 214: 3151-3169. PubMed: https://pubmed.ncbi.nlm.nih.gov/29061693/
  4. Dong X. Current Strategies for Brain Drug Delivery. Theranostics. 2018; 8: 1481–1493. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858162/
  5. Iadecola C. The pathobiology of vascular dementia. Neuron. 2013; 80: 844–866. PubMed: https://pubmed.ncbi.nlm.nih.gov/24267647/
  6. Iadecola C. The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease. Neuron. 2017; 96: 17–42. PubMed: https://pubmed.ncbi.nlm.nih.gov/28957666/
  7. Kisler K, Nelson AR, Montagne A, Zlokovic BV. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci. 2017; 18: 419–434. PubMed: https://pubmed.ncbi.nlm.nih.gov/28515434/
  8. Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV. Establishment and Dysfunction of the Blood-Brain Barrier. Cell. 2015; 163: 1064–1078. PubMed: https://pubmed.ncbi.nlm.nih.gov/26590417/
  9. Thurgur H, Pinteaux E. Microglia in the Neurovascular Unit: Blood–Brain Barrier–microglia Interactions After Central Nervous System Disorders. Neuroscience. 2018; 405 :55-67. PubMed: https://pubmed.ncbi.nlm.nih.gov/31007172
  10. Hawkins BT. The Blood-Brain Barrier/Neurovascular Unit in Health and Disease. Pharmacological Rev. 2005; 57: 173–185. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757302/
  11. Sweeney, Melanie D, Zlokovic BV. Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci. 2005; 19: 771-783. PubMed: https://pubmed.ncbi.nlm.nih.gov/27227366/
  12. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat Rev Neurosci. 2011; 12: 723–738. PubMed: https://pubmed.ncbi.nlm.nih.gov/22048062/
  13. Mancuso MR, Kuhnert F, Kuo CJ. Developmental angiogenesis of the central nervous system. Lymphat Res Biol. 2008; 6: 173–180. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712664/
  14. Posokhova E, Shukla A, Seaman S, Volate S, Hilton MB, et al. GPR124 functions as a WNT7-specific coactivator of canonical -catenin signaling. Cell Reports. 2015; 10: 123–130.
  15. Alvarez JI, Dodelet-Devillers A, Kebir H, Ifergan I, Fabre PJ, et al. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science. 2011; 334: 1727–1731. PubMed: https://pubmed.ncbi.nlm.nih.gov/22144466/
  16. Armulik A, Genové G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011; 21: 193–215. PubMed: https://pubmed.ncbi.nlm.nih.gov/21839917/
  17. Le Guelte A, Galan-Moya EM, Dwyer J, Treps L, Kettler G, et al. Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation. J Cell Sci. 2012; 125: 4137–4146. PubMed: https://pubmed.ncbi.nlm.nih.gov/22685328/
  18. Blanchette M, Daneman R. Formation and maintenance of the BBB. Mechanisms of Development. 2015; 138, 8–16. PubMed: https://pubmed.ncbi.nlm.nih.gov/26215350/
  19. Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013; 19: 1584-1596. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080800/
  20. Sun M, Ma K, Wen J, Wang G, Zhang C, et al. A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer’s Disease. J Alzheimers Dis. 73: 849-865. PubMed: https://pubmed.ncbi.nlm.nih.gov/31884474/
  21. Erickson MA, Banks WA. Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J Cereb Blood Flow Metab 2013; 33: 1500-1513. PubMed: https://pubmed.ncbi.nlm.nih.gov/23921899/
  22. Deane R, Bell RD, Sagare A, Zlokovic BV. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol Disord Drug Targets. 2009; 8: 16-30. PubMed: https://pubmed.ncbi.nlm.nih.gov/19275634/
  23. Yamada K, Hashimoto T, Yabuki C, Nagae Y, Tachikawa M, et al. The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells. J Biol Chem. 2008; 283: 34554-34562. PubMed: https://pubmed.ncbi.nlm.nih.gov/18940800/
  24. Ujiie M, Dickstein DL, Carlow DA, Jefferies WA. Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation. 2003; 10: 463-470. PubMed: https://pubmed.ncbi.nlm.nih.gov/14745459/
  25. Wu S, Liu H, Zhao H, Wang X, Chen J, et al. Environmental lead exposure aggravates the progression of Alzheimer's disease in mice by targeting on blood brain barrier. Toxicol Lett. 2020; 319: 138-147. PubMed: https://pubmed.ncbi.nlm.nih.gov/31730887/
  26. Shin Y, Choi SH, Kim E, Bylykbashi E, Kim JA, et al. Blood–Brain Barrier Dysfunction in a 3D In Vitro Model of Alzheimer’s Disease. Adv Sci. 2019; 6: 1900962. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794630/
  27. Miners JS, Kehoe PG, Love S, Zetterberg H, Blennow K. CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology. Alzheimers Res Ther. 2019; 11: 81: PubMed: https://pubmed.ncbi.nlm.nih.gov/31521199/
  28. Le Stunff H, Véret J, Kassis N, Denom J, Meneyrol K, et al. Deciphering the Link Between Hyperhomocysteinemia and Ceramide Metabolism in Alzheimer-Type Neurodegeneration. Front Neurol. 2019; 10; 807. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684947/
  29. He JT, Zhao X, Xu L, Mao CY. Vascular Risk Factors and Alzheimer's Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links. J Alzheimers Dis. 2020; 73: 39‐58. PubMed: https://pubmed.ncbi.nlm.nih.gov/31815697/
  30. Rivera S, García-González L, Khrestchatisky M, Baranger K. Metalloproteinases and their tissue inhibitors in Alzheimer’s disease and other neurodegenerative disorders. Cell Molecular Life Sci. 2019; 76: 3167-3191. PubMed: https://pubmed.ncbi.nlm.nih.gov/31197405/
  31. Ozkizilcik A, Sharma A, Lafuente JV, Muresanu DF, Castellani RJ, et al. Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson’s disease. Progress Brain Res. 2019; 201–246. PubMed: https://pubmed.ncbi.nlm.nih.gov/30961868/
  32. Matsumoto J, Stewart T, Sheng L, Li N, Bullock k, et al. Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?. Acta Neuropathol Commun. 2017; 5: 71. PubMed: https://pubmed.ncbi.nlm.nih.gov/28903781/
  33. Olmedo-Díaz S, Estévez-Silva H, Orädd G, Af Bjerkén S, Marcellino D, et al. An altered blood-brain barrier contributes to brain iron accumulation and neuroinflammation in the 6-OHDA rat model of Parkinson's disease. Neuroscience. 2017; 362: 141‐151. PubMed: https://pubmed.ncbi.nlm.nih.gov/28842186/
  34. Gray MT, Woulfe JM. Striatal blood-brain barrier permeability in Parkinson's disease. J Cereb Blood Flow Metab. 2015; 35: 747‐750. PubMed: https://pubmed.ncbi.nlm.nih.gov/25757748/
  35. Dohgu S, Takata F, Matsumoto J, Kimura I, Yamauchi A, et al. Monomeric α-synuclein induces blood–brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro. Microvascular Res. 2019. 124: 61-66. PubMed: https://pubmed.ncbi.nlm.nih.gov/30885616/
  36. Chung YC, Kim YS, Bok E, Yune TY, Maeng S, et al. MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson’s disease. Mediat Inflamm. 2013: 370526.
  37. Lerner RP, Francardo V, Fujita K, Bimpisidis Z, Jourdain VA, et al. Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia. Sci Rep. 2017; 7: 16005. PubMed: https://pubmed.ncbi.nlm.nih.gov/29167476/
  38. Ohlin KE, Sebastianutto I, Adkins CE, Lundblad C, Lockman PR, et al. Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease. Neuroimage. 2012; 61: 228‐239. PubMed: https://pubmed.ncbi.nlm.nih.gov/22406356/
  39. Duran-Vilaregut J, del Valle J, Manich G, Camins A, Pallas M, et al. Role of matrix metalloproteinase- 9(MMP-9) in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington’s disease. Neuropathol Appl Neuro. 2011; 37: 525–537. PubMed: https://pubmed.ncbi.nlm.nih.gov/21175737/
  40. Drouin-Ouellet J, Sawiak SJ, Cisbani G, Lagacé M, Kuan W, et al. Cerebrovascular and blood-brain barrier impairments in Huntington’s disease: potential implications for its pathophysiology. Ann Neurol. 2015; 78: 160–177. PubMed: https://pubmed.ncbi.nlm.nih.gov/25866151/
  41. Hsiao HY, Chen YC, Huang CH, Chen CC, Hsu Y, et al. Aberrant astrocytes impair vascular reactivity in Huntington disease. Ann Neurol. 2015; 78: 178‐192. PubMed: https://pubmed.ncbi.nlm.nih.gov/25914140/
  42. Lin CY, Hsu YH, Lin MH, Yang TH, Chen HM, et al. Neurovascular abnormalities in humans and mice with Huntington's disease. Exp Neurol. 2013; 250: 20‐30. PubMed: https://pubmed.ncbi.nlm.nih.gov/24036415/
  43. Lim RG, Quan C, Reyes-Ortiz AM, et al. Huntington's Disease iPSC-Derived Brain Microvascular Endothelial Cells Reveal WNT-Mediated Angiogenic and Blood-Brain Barrier Deficits. Cell Rep. 2017; 19: 1365‐1377. PubMed: https://pubmed.ncbi.nlm.nih.gov/28514657/
  44. Di Pardo A, Amico E, Scalabrì F, et al. Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease. Sci Rep. 2017; 7: 41316. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259798/
  45. Garbuzova-Davis S, Haller E, Saporta S, Kolomey I, Nicosia SV, et al. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res. 2007; 1157: 126‐137. PubMed: https://pubmed.ncbi.nlm.nih.gov/17512910/
  46. Miyazaki K, Ohta Y, Nagai M, et al. Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis. J Neurosci Res. 2011; 89: 718‐728. PubMed: https://pubmed.ncbi.nlm.nih.gov/21337372/
  47. Winkler EA, Sengillo JD, Sagare AP, et al. Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice. Proc Natl Acad Sci U S A. 2014; 111: E1035‐E1042. PubMed: https://pubmed.ncbi.nlm.nih.gov/24591593/
  48. Zhong Z, Ilieva H, Hallagan L, et al. Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. J Clin Invest. 2009; 119: 3437‐3449. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769191/
  49. Zhong Z, Deane R, Ali Z, et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci. 2008; 11: 420‐422. PubMed: https://pubmed.ncbi.nlm.nih.gov/18344992/
  50. Nicaise C, Mitrecic D, Demetter P, et al. Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res. 2009; 1301: 152‐162. PubMed: https://pubmed.ncbi.nlm.nih.gov/19748495/
  51. Evans MC, Serres S, Khrapitchev AA, Stolp HB, Anthony DC, et al. T₂-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS. J Cereb Blood Flow Metab. 2014; 34: 785-793. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013759/
  52. Andjus PR, Bataveljić D, Vanhoutte G, Mitrecic D, Pizzolante F, et al. In vivo morphological changes in animal models of amyotrophic lateral sclerosis and Alzheimer's-like disease: MRI approach. Anat Rec (Hoboken). 2009; 292: 1882-1892. PubMed: https://pubmed.ncbi.nlm.nih.gov/19943341/
  53. Bataveljić D, Nikolić L, Milosević M, Todorović N, Andjus PR. Changes in the astrocytic aquaporin-4 and inwardly rectifying potassium channel expression in the brain of the amyotrophic lateral sclerosis SOD1(G93A) rat model. Glia. 2012; 60: 1991‐2003. PubMed: https://pubmed.ncbi.nlm.nih.gov/22987392/
  54. Bataveljić D, Stamenković S, Bačić G, Andjus PR. Imaging cellular markers of neuroinflammation in the brain of the rat model of amyotrophic lateral sclerosis. Acta Physiol Hung. 2011; 98: 27‐31. PubMed: https://pubmed.ncbi.nlm.nih.gov/21388928/
  55. Garbuzova-Davis S, Saporta S, Haller E, et al. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One. 2007; 2: e1205. PubMed: https://pubmed.ncbi.nlm.nih.gov/18030339/
  56. Nicaise C, Soyfoo MS, Authelet M, et al. Aquaporin-4 overexpression in rat ALS model. Anat Rec (Hoboken). 2009; 292: 207‐213. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562093/
  57. Garbuzova-Davis S, Hernandez-Ontiveros DG, Rodrigues MC, et al. Impaired blood-brain/spinal cord barrier in ALS patients. Brain Res. 2012; 1469: 114‐128. PubMed: https://pubmed.ncbi.nlm.nih.gov/22750125/
  58. Wu Y, Yang X, Li X, Wang H, Wang T. Elevated cerebrospinal fluid homocysteine is associated with blood-brain barrier disruption in amyotrophic lateral sclerosis patients Neurol Sci. 2020; 41: 1865-1872. PubMed: https://pubmed.ncbi.nlm.nih.gov/32086685/
  59. Wang Y, Jin S, Sonobe Y, et al. Interleukin-1β induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes. PLoS One. 2014; 9: e110024. PubMed: https://pubmed.ncbi.nlm.nih.gov/25313834/
  60. Ticozzi N, Tiloca C, Mencacci NE, et al. Oligoclonal bands in the cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated mutations. J Neurol. 2013; 260: 85‐92. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196642/
  61. Henkel JS, Beers DR, Wen S, Bowser R, Appel SH. Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology. 2009; 72: 1614‐1616. PubMed: https://pubmed.ncbi.nlm.nih.gov/19414730/
  62. Garbuzova-Davis S, Woods RL 3rd, Louis MK, et al. Reduction of circulating endothelial cells in peripheral blood of ALS patients. PLoS One. 2010; 5: e10614. PubMed: https://pubmed.ncbi.nlm.nih.gov/20485543/
  63. Ortiz GG, Pacheco-Moisés FP, Macías-Islas MÁ, Flores-Alvarado LJ, Mireles-Ramírez MA, et al. Role of the blood-brain barrier in multiple sclerosis. Arch Med Res. 2014; 45: 687–697. PubMed: https://pubmed.ncbi.nlm.nih.gov/25431839/
  64. Alvarez JI, Cayrol R, Prat A. Disruption of central nervous system barriers in multiple sclerosis. Biochim Biophys Acta. 2011; 1812: 252–264. PubMed: https://pubmed.ncbi.nlm.nih.gov/20619340/
  65. Setiadi AF, Abbas AR, Jeet S, Wong K, Bischof A, et al. IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis. J Neuroimmunol. 2019; 332: 147–154. PubMed: https://pubmed.ncbi.nlm.nih.gov/31034962/
  66. Niu J, Tsai HH, Hoi KK, Huang N, Yu G, et al. Aberrant oligodendroglial-vascular interactions disrupt the blood-brain barrier, triggering CNS inflammation. Nat Neurosci. 2019; 22: 709-718. PubMed: https://pubmed.ncbi.nlm.nih.gov/30988524/
  67. Haarmann A, Schuhmann M, Silwedel C, Monoranu CM, Stoll G, et al. Human Brain Endothelial CXCR2 is Inflammation-Inducible and Mediates CXCL5- and CXCL8-Triggered Paraendothelial Barrier Breakdown. Int J Molecular Sci. 2019; 20: 602. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387364/
  68. Greene C, Hanley N, Campbell M. Claudin-5: gatekeeper of neurological function. Fluids and Barriers of the CNS. 2019; 16: 3. PubMed: https://pubmed.ncbi.nlm.nih.gov/30691500/
  69. Uchida Y, Sumiya T, Tachikawa M, et al. Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis. Mol Neurobiol. 2019; 56: 2039‐2056.
  70. Eisele P, Konstandin S, Szabo K, Ebert A, Roßmanith C, et al. Temporal evolution of acute multiple sclerosis lesions on serial sodium (23Na) MRI. Mult Scler Relat Disord. 2019; 29: 48–54. PubMed: https://pubmed.ncbi.nlm.nih.gov/30669020/
  71. Filippi M, Rocca MA, Martino G, Horsfield MA, Comi G. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol. 1998; 43: 809‐814.
  72. Vos CM, Geurts JJ, Montagne L, et al. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol Dis. 2005; 20: 953‐960. PubMed: https://pubmed.ncbi.nlm.nih.gov/16039866/
  73. Cramer SP, Modvig S, Simonsen HJ, Frederiksen JL, Larsson HB. Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis. Brain. 2015; 138: 2571‐2583. PubMed: https://pubmed.ncbi.nlm.nih.gov/26187333/
  74. Sheikh MH, Henson SM, Loiola RA, Mercurio S, Colamatteo A, et al. Immuno-metabolic impact of the multiple sclerosis patients' sera on endothelial cells of the blood-brain barrier. J Neuroinflammation. 2020; 17: 153. PubMed: https://pubmed.ncbi.nlm.nih.gov/32386505/
  75. Wang S, Millward JM, Hanke-Vela L, et al. MR Elastography-Based Assessment of Matrix Remodeling at Lesion Sites Associated With Clinical Severity in a Model of Multiple Sclerosis. Front Neurol. 2020; 10: 1382. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970413/
  76. Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, et al. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology. 2016; 86: 334 –340. PubMed: https://pubmed.ncbi.nlm.nih.gov/26718568/
  77. Jessen Krut J, Mellberg T, Price RW, Hagberg L, Fuchs D, et al. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients. PLoS One. 2014; 9: e88591. PubMed: https://pubmed.ncbi.nlm.nih.gov/24523921/
  78. Xing Y, Shepherd N, Lan J, Li W, Rane S, et al. MMPs/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders. Brain Behavior Immunity. 2017; 65: 161–172. PubMed: https://pubmed.ncbi.nlm.nih.gov/28487203/
  79. Strazza M, Pirrone V, Wigdahl B, Nonnemacher MR. Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res. 2011; 1399: 96–115. PubMed:. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139430/
  80. Niu F, Yao H, Zhang W, Sutliff RL, Buch S. Tat 101-mediated enhancement of brain pericyte migration involves platelet-derived growth factor subunit B homodimer: implications for human immunodeficiency virus-associated neurocognitive disorders. J Neurosci. 2014; 34: 11812–11825. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145180/
  81. Doherty CP, O’Keefe E, Wallace E, Loftus T, Keaney J, et al. Blood-Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic Encephalopathy. J Neuropathol Exp Neurol. 2016; 75: 656–662. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913433/
  82. Farrell M, Aherne S, O'Riordan S, O'Keeffe E, Greene C, Campbell M. Blood-brain barrier dysfunction in a boxer with chronic traumatic encephalopathy and schizophrenia. Clin Neuropathol. 2019; 38: 51-58. PubMed: https://pubmed.ncbi.nlm.nih.gov/30574863/
  83. Glushakova OY, Glushakov AO, Borlongan CV, Valadka AB, Hayes RL, et al. Role of Caspase-3-Mediated Apoptosis in Chronic Caspase-3-Cleaved Tau Accumulation and Blood–Brain Barrier Damage in the Corpus Callosum after Traumatic Brain Injury in Rats. J Neurotrauma. 2018; 35: 157–173.
  84. Demock M, Kornguth S. A Mechanism for the Development of Chronic Traumatic Encephalopathy From Persistent Traumatic Brain Injury. J Exp Neurosci. 2019; 13: 1179069519849935. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537483/
  85. Glushakova OY, Johnson D, Hayes RL. Delayed increases in microvascular pathology after experimental traumatic brain injury are associated with prolonged inflammation, blood-brain barrier disruption, and progressive white matter damage. J Neurotrauma. 2014; 31: 1180-1193. PubMed: https://pubmed.ncbi.nlm.nih.gov/24564198
  86. Keep RF, Xiang J, Ennis SR, Andjelkovic A, Hua Y, et al. Blood-brain barrier function in intracerebral hemorrhage. Acta Neurochir Suppl (Wien). 2008; 105: 73–77. PubMed: https://pubmed.ncbi.nlm.nih.gov/19066086/
  87. Khatri R, McKinney AM, Swenson B, Janardhan V. Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology. 2012; 79: S52–S57. PubMed: https://pubmed.ncbi.nlm.nih.gov/23008413/
  88. Prakash R, Carmichael ST. Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury. Curr Opin Neurol. 2015; 28: 556–564. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267616/
  89. Keaney J, Campbell M. The dynamic blood-brain barrier. FEBS J. 2015; 282: 4067–4079. PubMed: https://pubmed.ncbi.nlm.nih.gov/26277326/
  90. The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke. J Neuroinflammation. 2019; 16: 242. PubMed: https://pubmed.ncbi.nlm.nih.gov/31779652/
  91. Sarvari S, Moakedi F, Hone E, Simpkins JW, Ren X. Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke. Metab Brain Dis. 2020; 35: 851-868. PubMed: https://pubmed.ncbi.nlm.nih.gov/32297170/
  92. Guo F, Xu D, Lin Y, et al. Chemokine CCL2 contributes to BBB disruption via the p38 MAPK signaling pathway following acute intracerebral hemorrhage. FASEB J. 2020; 34: 1872-1884. PubMed: https://pubmed.ncbi.nlm.nih.gov/31914700/
  93. Li Y, Wu P, Bihl JC, Shi H. Underlying Mechanisms and Potential Therapeutic Molecular Targets in Blood-Brain Barrier Disruption after Subarachnoid Hemorrhage. Curr Neuropharmacol. 2020; 18: 1168-1179. PubMed: https://pubmed.ncbi.nlm.nih.gov/31903882/
  94. Victoria ECG, Toscano ECB, Oliveira FMS, et al. Up-regulation of brain cytokines and metalloproteinases 1 and 2 contributes to neurological deficit and brain damage in transient ischemic stroke. Microvasc Res. 2020; 129: 103973. PubMed: https://pubmed.ncbi.nlm.nih.gov/31891716/
  95. Bas¸kaya MK, Rao AM, Dog˘an A, Donaldson D, Dempsey RJ. The biphasic opening of the blood-brain barrier in the cortex and hippocampus after traumatic brain injury in rats. Neurosci Lett. 1997; 226: 33–36. PubMed: https://pubmed.ncbi.nlm.nih.gov/9153635/
  96. Habgood MD, Bye N, Dziegielewska KM, Ek CJ, Lane MA, et al. Changes in blood-brain barrier permeability to large and small molecules following traumatic brain injury in mice. Eur J Neurosci. 2007; 25: 231–238. PubMed: https://pubmed.ncbi.nlm.nih.gov/17241284/
  97. Kawoos U, Abutarboush R, Zarriello S, Qadri A, Ahlers ST, et al. N-acetylcysteine Amide Ameliorates Blast-Induced Changes in Blood-Brain Barrier Integrity in Rats. Front Neurol. 2019; 10: 650. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607624/
  98. Szarka N, Toth L, Czigler A, Kellermayer Z, Ungvari Z, et al. Single Mild Traumatic Brain Injury Induces Persistent Disruption of the Blood-Brain Barrier, Neuroinflammation and Cognitive Decline in Hypertensive Rats. Int J Molecular Sci. 2019; 20: 3223. PubMed: https://pubmed.ncbi.nlm.nih.gov/31262044/
  99. Kuriakose M, Younger D, Ravula AR, Alay E, Rama Rao KV, et al. Synergistic Role of Oxidative Stress and Blood-Brain Barrier Permeability as Injury Mechanisms in the Acute Pathophysiology of Blast-induced Neurotrauma. Sci Rep. 2019; 9: 7717.
  100. Michinaga S, Koyama Y. Dual Roles of Astrocyte-Derived Factors in Regulation of Blood-Brain Barrier Function after Brain Damage. Int J Molecular Sci. 2019; 20: 571. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387062/
  101. Price L, Wilson C, Grant G. Frontiers in neuroscience blood-brain barrier pathophysiology following traumatic brain injury. In Translational Research in Traumatic Brain Injury; Laskowitz, D, Grant, G, Eds.; CRC Press/Taylor and Francis Group©: Boca Raton, FL, USA, 2016. PubMed: https://pubmed.ncbi.nlm.nih.gov/26583184/
  102. Hay JR, Johnson VE, Young AM, Smith DH, Stewart W. Blood-Brain Barrier Disruption Is an Early Event That May Persist for Many Years After Traumatic Brain Injury in Humans. J Neuropathol Exp Neurol. 2015; 74: 1147-1157. PubMed: https://pubmed.ncbi.nlm.nih.gov/26574669/
  103. Johnson VE, Weber MT, Xiao R, et al. Mechanical disruption of the blood-brain barrier following experimental concussion. Acta Neuropathol. 2018; 135: 711-726. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532777/
  104. Hagos FT, Empey PE, Wang P, et al. Exploratory Application of Neuropharmacometabolomics in Severe Childhood Traumatic Brain Injury. Crit Care Med. 2018; 46: 1471-1479. PubMed: https://pubmed.ncbi.nlm.nih.gov/29742587/
  105. Higashida T, Kreipke CW, Rafols JA, et al. The role of hypoxia-inducible factor-1α, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury. J Neurosurg. 2011; 114: 92-101. PubMed: https://pubmed.ncbi.nlm.nih.gov/20617879/
  106. Pan R, Yu K, Weatherwax T, Zheng H, Liu W, et al. Blood Occludin Level as a Potential Biomarker for Early Blood Brain Barrier Damage Following Ischemic Stroke. Sci Rep. 2017; 7: 40331. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228160/
  107. Zongo D, Ribéreau-Gayon R, Masson F, et al. S100-B protein as a screening tool for the early assessment of minor head injury. Ann Emerg Med. 2012; 59: 209-218 PubMed: https://pubmed.ncbi.nlm.nih.gov/21944878/
  108. Neher MD, Keene CN, Rich MC, Moore HB, Stahel PF. Serum biomarkers for traumatic brain injury. South Med J. 2014; 107: 248-255. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774463/
  109. Pham N, Akonasu H, Shishkin R, Taghibiglou C. Plasma soluble prion protein, a potential biomarker for sport-related concussions: a pilot study. PLoS One. 2015; 10: e0117286. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314282/
  110. Rigau V, Morin M, Rousset MC, de Bock F, Lebrun A, et al. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain. 2007; 130: 1942-1956. PubMed: https://pubmed.ncbi.nlm.nih.gov/17533168/
  111. Swissa E, Serlin Y, Vazana U, Prager O, Friedman A. Blood-brain barrier dysfunction in status epileptics: Mechanisms and role in epileptogenesis. Epilepsy Behav. 2019; 101: 106285. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842020/
  112. Kim SY, Buckwalter M, Soreq H, Vezzani A, Kaufer D. Blood-brain barrier dysfunction-induced inflammatory signaling in brain pathology and epileptogenesis. Epilepsia. 2012; 53: 37-44. PubMed: https://pubmed.ncbi.nlm.nih.gov/23134494/
  113. Giza CC, Hovda DA. The new neurometabolic cascade of concussion. Neurosurgery. 2014; 75: S24-S33. PubMed: https://pubmed.ncbi.nlm.nih.gov/25232881
  114. Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol. 2011; 7: 31-40. PubMed: https://pubmed.ncbi.nlm.nih.gov/21135885
  115. van Vliet EA, da Costa Araújo S, Redeker S, van Schaik R, Aronica E, et al. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain. 2007; 130: 521-534. PubMed: https://pubmed.ncbi.nlm.nih.gov/17124188/
  116. Van Vliet EA, Aronica E, Gorter JA. Role of blood-brain barrier in temporal lobe epilepsy and pharmacoresistance. Neuroscience. 2017; 277: 455-473. PubMed: https://pubmed.ncbi.nlm.nih.gov/25080160/
  117. Liu XX, Yang L, Shao LX, et al. Endothelial Cdk5 deficit leads to the development of spontaneous epilepsy through CXCL1/CXCR2-mediated reactive astrogliosis. J Exp Med. 2020; 217: e20180992. PubMed: https://pubmed.ncbi.nlm.nih.gov/31699822/
  118. Dadas A, Janigro D. Breakdown of blood brain barrier as a mechanism of post-traumatic epilepsy. Neurobiol Dis. 2019; 123: 20-26. PubMed: https://pubmed.ncbi.nlm.nih.gov/30030025/
  119. Gorter JA, Aronica E, van Vliet EA. The Roof is Leaking and a Storm is Raging: Repairing the Blood–Brain Barrier in the Fight Against Epilepsy. Epilepsy Currents. 2019; 19: 177–181. PubMed: https://pubmed.ncbi.nlm.nih.gov/31037960
  120. Broekaart DWM, Anink JJ, Baayen JC, Idema S, de Vries HE, et al. Activation of the innate immune system is evident throughout epileptogenesis and is associated with blood-brain barrier dysfunction and seizure progression. Epilepsia. 2018; 59: 1931-1944. PubMed: https://pubmed.ncbi.nlm.nih.gov/30194729/
  121. Greene C, Kealy J, Humphries MM, et al. Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia. Mol Psychiatry. 2018; 23: 2156-2166. PubMed: https://pubmed.ncbi.nlm.nih.gov/28993710/
  122. Maes M, Vojdani A, Geffard M, et al. Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways. Biomol Concepts. 2019; 10: 209-225. PubMed: https://pubmed.ncbi.nlm.nih.gov/31734647
  123. Maes M, Sirivichayakul S, Kanchanatawan B, Vodjani A. Breakdown of the Paracellular Tight and Adherens Junctions in the Gut and Blood Brain Barrier and Damage to the Vascular Barrier in Patients with Deficit Schizophrenia. Neurotox Res. 2019; 36: 306-322. PubMed: https://pubmed.ncbi.nlm.nih.gov/31077000/
  124. Raza MW, Shad A, Pedler SJ, Karamat KA. Penetration and activity of antibiotics in brain abscess. J Coll Physicians Surg Pak. 2005; 15: 165–167. PubMed: https://www.ncbi.nlm.nih.gov/m/pubmed/15808097
  125. Yang RC, Qu XY, Xiao SY, Li L, Xu BJ, et al. Meningitic Escherichia coli-induced upregulation of PDGF-B and ICAM-1 aggravates blood-brain barrier disruption and neuroinflammatory response. J Neuroinflammation. 2019; 16: 101. PubMed: https://pubmed.ncbi.nlm.nih.gov/31092253/
  126. Ma Z, Peng J, Yu D, Park JS, Lin H, et al. A streptococcal Fic domain-containing protein disrupts blood-brain barrier integrity by activating moesin in endothelial cells. PLoS Pathog. 2019; 15: e1007737. PubMed: https://pubmed.ncbi.nlm.nih.gov/31071198/
  127. Chen J, Li N, Wang B, Liu X, Liu J, et al. Upregulation of CBP by PLY can cause permeability of blood-brain barrier to increase meningitis. J Biochem Mol Toxicol. 2019; 33: e22333. PubMed: https://pubmed.ncbi.nlm.nih.gov/30980515/
  128. Thorsdottir S, Henriques-Normark B, Iovino F. The Role of Microglia in Bacterial Meningitis: Inflammatory Response, Experimental Models and New Neuroprotective Therapeutic Strategies. Front Microbiol. 2019; 10: 576. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442515/
  129. Silwedel C, Haarmann A, Fehrholz M, Claus H, Speer CP, et al. More than just inflammation: Ureaplasma species induce apoptosis in human brain microvascular endothelial cells. J Neuroinflammation. 2019; 16: 38. PubMed: https://pubmed.ncbi.nlm.nih.gov/30764830/

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Contact

Editorial Office Emails:

info@hspioa.org

amelia.sandra@hspioa.us

elena.maya@hspioa.us

Select by Volume & Issue

Submit Manuscript Information for Authors Advisory Board Rss Feed Articles Rss Feed

Most Viewed Keywords

University/Institution

Select and search by University/Institution.

Articles by Country

Select and search by country to get related articles.

Testmonials

I would like to thank JPRA for taking this decision. I understand the effort it represents for you. I'm truly happy to have the paper published in JPRA. And I'll certainly consider JPRA for my next publications as I was satisfied of the service provided, the efficiency and promptness of the interactions we had.

Emmanuel BUSATO

Publishing with the International Journal of Clinical and Experimental Ophthalmology was a rewarding experience as review process was thorough and brisk. Their visibility online is second to none as their published articles appear in all search engines. I will encourage researchers to publish with them.

Elizabeth Awoyesuku

“The choice to submit the forensic case study to the Journal of Addiction Therapy and Research was dictated by the match between the content and the potential readership. The publication process proved to be expedient and we were provided with constructive feedback from reviewers. The final article layout is attractive and conforms to standards. All-in-all, it has been a rewarding process.”

Elisabeth H Wiig

Archives of Vascular Medicine is one of the top class journal for vascular medicine with highly interesting topics. You did a professional and great Job!

Elias Noory

Thank you very much. I think the review process and all of what concerns the administration of the publication concerning our paper has been excellent. The nice and quick answers have been very good I think.

Doris Nilsson

Journal of Pulmonary and Respiratory Research is good journal for respiratory research purposes. It takes 2-3 weeks maximum for review of the manuscript to get published and any corrections to be made in the manuscript. It needs good articles and studies to get publish in the respiratory medicine. I am really glad that this journal editors helped me to get my case report published.

Divya Khanduja

Thanks you and your colleague for the great help for our publication. You always provide prompt responses and high quality of service. I am so happy to have you working with me. Thanks again!

Diana (Ding) Dai

Service and process were excellent as was the “look” of the article when published.

Deane Waldman

Great, thank you! It was very efficient working w/ your group. Very thorough reviews (i.e., plagiarism, peer, etc.). Would certainly recommend that future authors consider working w/ your group.

David W Brett

Your services are very good

Chukwuka Ireju Onyinye

I very much appreciate the humanitarian services provided in my stead by this journal/publisher. It exhibits total absence of editorial impertinence. As an Author, I have been guided to have a fruitful experience. The editorial care is highly commendable.

Chrysanthus Chukwuma

"An amazing experience with the Journal of Advanced Pediatrics and Child Health. Very fast blind review with pertinent corrections and suggestions. I highly recommand both the journal and the editor."

Chaimae Khairoun

The submission is very easy and the time from submission to response from the reviewers is short. Correspondence with the journal is nice and rapid.

Catrin Henriksson

The Clinical Journal of Obstetrics and Gynecology is an open access journal focused on scientific knowledge publication with emphasis laid on the fields of Gynecology and Obstetrics. Their services toward us have been encouraging through their kindness and respect. Great consideration has been given to us as young budding researchers and we are very grateful for this.

Carole Assontsa

During the process your positive communication, prompt feedback and professional approach is very highly appreciated. We would like to thank you very much for your support.

Can Vuran

I do appreciate for your service including submission, analysis, review, editorial and publishing process. I believe these esteemed journal enlighten the science with its high-quality personel.

Bora Uysal

I am very much pleased with the fast track publication by your reputed journal's editorial team. It is really helpful for researchers like me from developing nations. I strongly recommend your journal for publication.

Badri Kumar Gupta

It has been a fabulous journey writing articles for your journal because of the encouragement you people provide for writers from developing nations like India. Kindly continue the same. Looking forward for a long term association.

Badareesh Lakshminarayana

Many thanks for publishing my article in your great journal and the friendly and hassle-free publication process, the constructive peer-review, the regular feedback system, and the Quick response to any queries.

Azab Elsayed Azab

I would like to thank this journal for publishing my Research Article. Something I really appreciate about this journal is, they did not take much time from the day of Submission to the publishing date. Looking forward to have more publications in future.

Ayush Chandra

Submission of paper was smooth, the review process was fast. I had excellent communication and on time response from the editor.

Ayokunle Dada

Your service is very good and fast reply, also your service understand our situation and support us to publication our articles.

Ayman M Abu Mustafa

Really good service with prompt response. Looking forward to having long lasting relationship with your journal

Avishek Bagchi

Your service is excellent. Processing and editing were very fast. I hope to publish more of my works in your journal.

Ausraful Islam

I wanna to thank Clinical Journal of Nursing Care and Practice for its effort to review and publish my manuscript. This is reputable journal. Thank you!

Atsedemariam Andualem

“It was a delightful experience publishing my manuscript with the Clinical Journal of Obstetrics and Gynecology. They offered me lots of opportunities I never had from most publishing houses and their prompt services are greatly appreciated.”

Asafo Jones

I hope to ability to make some new investigation and publish in Your Company in future.

Artur Stopyra

I like the quality of the print & overall service. The paper looks quite impressive. Hope this will attract interested readers. All of you have our best wishes for continued success.

Arshad Khan

Your big support from researchers around the world is the best appreciation from your scientific teams. We believe that there should be no barrier in science and you make it real and this motto come true.

Arefhosseinir Rafi

Your journal co-operation is very appreciable and motivational. I am really thankful to your journal and team members for the motivation and collaboration to publish my work.

Assistant Professor, UCLAS Uttaranchal University, Dehradun, India

Archna Dhasmana

I am glad to submit the article to Heighten Science Publications as it has a very smooth and fast peer-review process, which enables the researchers to communicate their work on time.

Anupam M

This is to specify that I have had an extensive and detailed interaction with the Editorial team of Annals of Clinical Gastroenterology and Hepatology, USA, lasting over a significant period of time. My interaction has been extremely pleasant, especially with Ms Allie Smith, as I find the communication quite inspiring and crystal clear. The attitude of aforesaid individuals is quite helpful and guiding in pertinent instances. It has been a commemorative journey so far working with the Journal and I hope that the symbiosis will continue, evolve and flourish in the forthcoming years. I wish the journal, related personnel and aforementioned individuals a fruitful, successful run.

New Delhi, India

Anubha Bajaj

We appreciate the fact that you decided to give us full waiver for the applicable charges and approve the final version. You did an excellent job preparing the PDF version. Of course we will consider your magazine for our future submissions and we will pay the applicable fees then.

Anna Dionysopoulou

''Co-operation of Archives of Surgery and Clinical Research journal is appreciable. I'm impressed at the promptness of the publishing staff and the professionalism displayed. Thank you very much for your support, help and encouragement.''

Anıl Gokce

Congratulations for the excellence of your journal and high quality of its publications.

Angel MARTIN CASTELLANOS

The service from the journal staff has been excellent.

Andy Smith

I was very pleased with the quick editorial process. We are sure that our paper will have great visibility, among other things due to its open access. We believe in science accessible to all.

Anderson Fernando de Souza

It was a great experience publishing through JCICM. The article has reached out to several institutions. Appreciate your professional work. Hope to work with you again

Anas Wardeh

Publishing an article is a long process, but working with your publication department made things go smoothly, even though the process took exactly 5 months from the time of submitting the article till the time I have favourable response, the missing part is the peer review details, which is essential in self auditing and future improvement, overall experience was excellent giving your understanding of the situation of lack of financial institution support.

Anas Diab

I think that Heighpubs very good. You are very helpful. Thank you for everything.

Ana Ribeiro

Regarding to be services, we note that are work with high standards of professionalism translated into quick response, efficiency which makes communication accessible. Furthermore, I believe to be much inviting for the submission of future works for publication purposes.

Amélia João Alice Nkutxi

I would like to mention that I had a wonderful experience working with HSPI. The whole process right from manuscript submission to peer review till the publication of the article was very prompt & efficient. I wish you good luck for the future.

Amarjeet Gambhir

Once I submitted the manuscript, the response time of the reviewers was very fast. The fine-tuning of the galley proof was likewise prompt. I believe the journal provide a valuable outlet to disseminate physical rehabilitation scientific knowledge to the clinical community. Respectfully. Dr. Alon

Alon

We really appreciate and thanks the full waiver you provide for our article. We happy to publish our paper in your journal. Thank you very much for your good support and services.

Ali Abusafia

It was a real pleasure working with your team. The review was done fast, and it was very clear, the editing was flawless, the article was published quickly compared to other journals, and everyone was understanding and helpful. I will gladly recommend this journal to my acquaintances in academia.

Alexandra Cozma

To the editorial team at HSPI and the Journal of Clinical Nephrology: Thank you so much for your hard work and collaboration in bringing our article to life. Your staff was responsive, flexible, and communicative and made the process smooth and easy. Thank you!

Alejandro Munoz

Dear colleagues! I am satisfied with our cooperation with you. Your service is at a high level. I hope for a future relationship. Let me know if I can get a paper version of the magazine with my articles from you. I see them on the Internet.

Aksenov V.V

"This is my first time publishing with the journal/publisher. I am impressed at the promptness of the publishing staff and the professionalism displayed. Thank you for encouraging young researchers like me!"

Ajite Kayode

I want to thank you for our collaboration. You were fast and effective with a positive spirit of teamwork. I am truly excited from our collaboration. You were like always fast, efficient and accurate. I hope that in the near future we will collaborate again.

Aikaterini Solomou

In my opinion, you provide a very fast and practical service.

Ahmet Eroglu

Great, We are too comfortable with the process including the peer review process and quality. But, the journal should be indexed in different databases such scopus.

Afework Edmealem

We really appreciate your efforts towards our article, the professional way you handle our request for exemption from charges. It was a great honor for us to publish in your magazine.

Achraf elbakkaly

I really liked the ease of submitting my manuscript in the HSPI journal. Further, the peer review was timely completed and I was communicated the final decision on my manuscript within 10 days of submission which is really appreciable. I strongly recommend all the scientists and researchers to submit their work in this journal”

Abu Bashar

My candid opinion is that the service you render is second to none. My favourite part is the prompt response to issue, really i value that.

Abiodun Akanbi Adeogun

Thank you very much for accepting our manuscript in your journal “International Journal of Clinical Virology”. We are very thankful to the esteemed team for timely response and quick review process. The editorial team of International Journal of Clinical Virology is too cooperative and well-mannered during the publication process. We are hopeful to publish many quality papers in your journal and I suggest the International Journal of Clinical Virology to all of my colleagues, researchers and friends to publish their research here.

Abdul Baset

I, Muhammad Sarwar Khan, am serving as Editor on Archives of Biotechnology and Biomedicine (ABB). I submitted an editorial titled, 'Edible vaccines to combat Infectious Bursal Disease of poultry' for publication in ABB. After submitting the manuscript; the services rendered by the management and technical personnel to handle and process the manuscript were marvelous. Plagiarism report was shared with me with complements before reviewers' comments, All steps including article processing and service charges were well taken care of keeping in view the author's interest/preference. All together, it was an encouraging and wonderful experience working with ABB personnel.

University of Agriculture, Pakistan

Muhammad Sarwar Khan

Your journal has accomplished its intended mission of providing very effective and efficient goals in dealing with submissions, conducting the reviewing process and in publishing accepted manuscripts in a timely manner. Keep up the great work and services that you provide.

University of Jacqmar, Inc., USA

John St. Cyr

I am to express my view that Heighten Science Publications are reliable quick even after peer review process. I hope and wish the publications will go a long way in disseminating science to many interested in scientific research.

College of Fisheries, CAU(I), Tripura, India

Ajit Kumar Roy

The Journal Clinical Nephrology provides a good opportunity for readers to stay updated in the field of clinical nephrology. Additionally - it provides a good opportunity for authors to publish their work. 1. Publication of the accepted manuscripts is sufficiently rapid. 2. The trust factor between the journal and me, as an author, is very important and well preserved. 3. Peer review process very rapid and effective.

Assaf Harofeh Medical Center, Israel

Leonid Feldman

In 2017, I submitted a manuscript to the journal Archives of Biotechnology and Biomedicine belonging to Heighten Science Publications Corporation. Within one week I already received the response from the editor. All processing steps were really fast so in terms of a speedy publication I can particularly recommend the journal Archives of Biotechnology and Biomedicine. The responsible contact person of the journal was always available, which gives a trustworthy impression to the author. Also the peer review process was clear and constructive. So from my experience with Heighten Science Publications Corporation I can recommend publishing there.

University of Tubingen, Germany

Yvonne Mast

We thank to the heighten science family, who speed up the publication of our article and provide every support.

Mehmet Besir

The services of the journal were excellent. The most important thing for an author is the speed of the peer review which was really fast here. They returned in a few days and immediately replied all of my questions. I want to refer this platform to all scholars. Many thanks.

Eastern Mediterranean University, Cyprus

Zehra Guchan TOPCU

Thank you for your attitude and support. I am sincerely grateful to you and the entire staff of the magazine for the high professionalism and fast quality work. Thank you very much!

USA

Igor Klepikov

Thank you and your company for effective support of authors which are very much dependable on the funds gambling for science in the different countries of our huge and unpredictable world. We are doing our work and should rely on a teams like Galley Proof-HSPC. Great success to all of you for the 2019th! Be well all the year long.

Russia

Victor V Apollonov

The editorial process was quickly done. The galley proof was sent within a week after being accepted for publication. The editorial team was very helpful and responded promptly.

India

Rohit Kulshrestha

Publishing with the International Journal of Clinical and Experimental Ophthalmology was a rewarding experience as review process was thorough and brisk. Their visibility online is second to none as their published articles appear in all search engines. I will encourage researchers to publish with them.

University of Port Harcourt Teaching Hospital, Nigeria

Dr. Elizabeth A Awoyesuku

"It was a pleasure to work with the editorial team of the journal on the submission of the manuscript. The team was professional, fast, and to the point".

NC A&T State University, USA

Moran Sciamama-Saghiv

Submission of paper was smooth, the review process was fast. I had excellent communication and on time response from the editor.

Ekiti State University Teaching Hospital, Nigeria

Ayokunle Dada

I am delighted and satisfied with. Heighten Science Publications as my manuscript was thoroughly assessed and published on time without delay. Keep up the good work.

Ido-Ekiti/Afe Babalola University, Nigeria

Dr. Shuaib Kayode Aremu

"This is my first time publishing with the journal/publisher. I am impressed at the promptness of the publishing staff and the professionalism displayed. Thank you for encouraging young researchers like me!"

Ekiti State University, Nigeria

Adebukola Ajite

I wanna to thank clinical journal of nursing care and practice for its effort to review and publish my manuscript. This is reputable journal. Thank you!

Wollo University, Ethiopia

Atsedemariam Andualem

We appreciate your approach to scholars and will encourage you to collaborate with your organization, which includes interesting and different medical journals. With the best wishes of success, creativity and joy in life, prosperity in the medical field.

Ivano- Frankivsk National Medical University, Ukraine

Nataliya Kitsera

Thank you very much for your support and encouragement. I am truly impressed by your tolerance and support. Thank you very much

Diaverum: PADC, Jeddah, Saudi Arabia

Nasrulla Abutaleb

You are such a nice person. Your journal co-operation is very appreciable and motivational.

Department of Biotechnology, Uttaranchal college of Applied and Life Sciences, Uttaranchal University, Dehradun, Uttarakhand, India

Archna Dhasmana

“Mobile apps and wearable technology are becoming ubiquitous in our environment. Their integration with healthcare delivery is just beginning to take shape. The early results are promising and the possibilities great."

BS, PharmD., MBA, CPHIMS, FHIMSS, Adjunct Professor, Global Healthcare Management, MCPHS University, Chief Strategy Offi cer, MedicaSoft, Senior Advisor, National Health IT (NHIT) Collaborative for Underserved, New York HIMSS, National Liaison, Health 2.0 Boston, Past Chair, Chair Innovation, USA

Helen Figge

“The choice to submit the forensic case study to the Journal of Addiction Therapy and Research was dictated by the match between the content and the potential readership. The publication process proved to be expedient and we were provided with constructive feedback from reviewers. The final article layout is attractive and conforms to standards. All-in-all, it has been a rewarding process.”

Ph.D, Boston University Department of Communication Sciences and Disorders and Knowledge Research Institute, Inc., 2131 Reflection Bay Drive, Arlington, Texas 76013, USA

Elisabeth H. Wiig

The service is nice and the time of processing the application is fast.

Department of Neurosurgery, Queen Elizabeth Hospital, Hong Kong

Long Ching

Your service is very good and fast reply, Also your service understand our situation and support us to publication our articles.

Palestine College of Nursing, Khan Younis, Gaza Strip, Palestine

Ayman M Abu Mustafa

“It was a delightful experience publishing my manuscript with the Clinical Journal of Obstetrics and Gynecology. They offered me lots of opportunities I never had from most publishing houses and their prompt services are greatly appreciated.”

Department of Agricultural Economics, Agribusiness and Extension, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

Akowuah Jones Asafo

View More

Related Journals

Help ?